| Primary |
| Renal Cell Carcinoma |
28.1% |
| Metastatic Renal Cell Carcinoma |
14.4% |
| Hypertension |
7.7% |
| Renal Cancer Metastatic |
7.7% |
| Mantle Cell Lymphoma |
7.0% |
| Premedication |
6.5% |
| Renal Cancer |
4.8% |
| Renal Cell Carcinoma Stage Unspecified |
4.0% |
| Pain |
3.8% |
| Prophylaxis |
2.7% |
| Diabetes Mellitus |
2.1% |
| Nausea |
2.1% |
| Prostate Cancer |
1.5% |
| Acute Myeloid Leukaemia |
1.3% |
| Endometrial Cancer |
1.3% |
| Head And Neck Cancer |
1.2% |
| Neoplasm Malignant |
1.1% |
| Uterine Leiomyosarcoma |
0.9% |
| Glioblastoma Multiforme |
0.9% |
| Epilepsy |
0.9% |
|
| Disease Progression |
11.2% |
| Death |
10.4% |
| Rash |
7.9% |
| Thrombocytopenia |
7.9% |
| Renal Failure |
4.9% |
| Renal Failure Acute |
4.9% |
| Interstitial Lung Disease |
4.8% |
| Pneumonia |
4.8% |
| Vomiting |
4.6% |
| Pyrexia |
4.3% |
| Respiratory Failure |
4.3% |
| Pneumonitis |
3.9% |
| Stomatitis |
3.7% |
| Renal Cell Carcinoma |
3.6% |
| Blood Creatinine Increased |
3.3% |
| Mucosal Inflammation |
3.3% |
| Rash Pruritic |
3.3% |
| Extravasation |
3.1% |
| Nausea |
2.8% |
| Pleural Effusion |
2.8% |
|
| Secondary |
| Renal Cell Carcinoma |
18.7% |
| Metastatic Renal Cell Carcinoma |
11.7% |
| Premedication |
11.6% |
| Mantle Cell Lymphoma |
10.4% |
| Hypertension |
8.4% |
| Renal Cancer Metastatic |
6.3% |
| Pain |
5.3% |
| Renal Cancer |
4.1% |
| Mantle Cell Lymphoma Recurrent |
3.2% |
| Metastatic Squamous Cell Carcinoma |
2.8% |
| Drug Use For Unknown Indication |
2.7% |
| Prophylaxis |
2.6% |
| Diabetes Mellitus |
2.1% |
| Ear Neoplasm Malignant |
1.5% |
| Head And Neck Cancer Metastatic |
1.5% |
| Malignant Neoplasm Of Eye |
1.5% |
| Throat Cancer |
1.5% |
| Nausea |
1.4% |
| Convulsion |
1.3% |
| Product Used For Unknown Indication |
1.3% |
|
| Thrombocytopenia |
19.4% |
| Pyrexia |
11.0% |
| Renal Cell Carcinoma |
8.4% |
| Septic Shock |
7.9% |
| Weight Decreased |
6.8% |
| General Physical Health Deterioration |
4.2% |
| Lung Disorder |
3.7% |
| Rash |
3.7% |
| Renal Cancer Metastatic |
3.7% |
| Renal Failure Acute |
3.7% |
| Idiopathic Thrombocytopenic Purpura |
3.1% |
| Pleural Effusion |
3.1% |
| White Blood Cell Count Decreased |
3.1% |
| Diabetes Mellitus Inadequate Control |
2.6% |
| Disease Progression |
2.6% |
| Hyperkalaemia |
2.6% |
| Osteonecrosis |
2.6% |
| Proteinuria |
2.6% |
| Renal Failure |
2.6% |
| Skin Hyperpigmentation |
2.6% |
|
| Concomitant |
| Metastatic Renal Cell Carcinoma |
21.3% |
| Renal Cell Carcinoma |
10.2% |
| Drug Use For Unknown Indication |
7.4% |
| Hypertension |
6.5% |
| Product Used For Unknown Indication |
5.6% |
| Prophylaxis |
5.1% |
| Neoplasm |
4.6% |
| Neoplasm Malignant |
4.6% |
| Nuclear Magnetic Resonance Imaging |
4.6% |
| Bone Disorder |
4.2% |
| Pain |
4.2% |
| Renal Cancer |
3.7% |
| Anxiety |
2.8% |
| Constipation |
2.8% |
| Gastric Ulcer |
2.8% |
| Benign Prostatic Hyperplasia |
2.3% |
| Cervicobrachial Syndrome |
1.9% |
| Convulsion Prophylaxis |
1.9% |
| Hyperuricaemia |
1.9% |
| Metastases To Bone |
1.9% |
|
| Renal Cell Carcinoma |
10.6% |
| Blood Lactate Dehydrogenase Increased |
8.5% |
| Death |
8.5% |
| Skin Fibrosis |
8.5% |
| Tremor |
8.5% |
| Neoplasm Malignant |
6.4% |
| Neoplasm Progression |
6.4% |
| Constipation |
4.3% |
| Disease Progression |
4.3% |
| General Physical Health Deterioration |
4.3% |
| Muscle Spasms |
4.3% |
| Osteoarthritis |
4.3% |
| Osteonecrosis Of Jaw |
4.3% |
| Renal Disorder |
4.3% |
| Blood Bilirubin Increased |
2.1% |
| Blood Glucose Increased |
2.1% |
| Bone Pain |
2.1% |
| Cardiac Failure |
2.1% |
| Colonic Stenosis |
2.1% |
| Denture Wearer |
2.1% |
|
| Interacting |
| Metastatic Renal Cell Carcinoma |
33.3% |
| Brain Metastases |
16.7% |
| Hypertension Arterial |
16.7% |
| Lung Metastases |
16.7% |
| Renal Cancer |
16.7% |
|
| Toxic Skin Eruption |
66.7% |
| Weight Increased |
33.3% |
|
